Stock Screener App

Frei -

Installieren

6.80

1.04% 0.07

after-market

Handel nachbörslich: 6.80

Day One Biopharmaceuticals Inc (DAWN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	12.18% 66.77	59.52	51.44	49.25	45.85
Operating Income/Loss	12.18% -66.77	-59.52	-51.44	-49.25	-45.85
Income/Loss From Continuing Operations Before Tax	14.49% -62.41	-54.51	-46.15	-45.86	-42.39
Income/Loss From Continuing Operations After Tax	14.49% -62.41	-54.51	-46.15	-45.86	-42.39
Net Income/Loss	14.49% -62.41	-54.51	-46.15	-45.86	-42.39
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4,046% 86.68	2.0908	85.95	74.96	71.97
Diluted Average Shares	4,046% 86.68	2.0908	85.95	74.96	71.97
Basic Earnings Per Share	12.50% -0.72	-0.64	-0.54	-0.61	-0.59
Diluted Earnings Per Share	12.50% -0.72	-0.64	-0.54	-0.61	-0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$20.30

0.68%

RPRX

$36.37

0.50%

SMMT

$24.55

8.53%

INSM

$97.80

0.45%

BNTX

$110.00

1.61%

ONC

$245.49

0.48%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters